VTRS Q1 2017 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena

VTRSViatris Inc.

$16B

Q1 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2.7B+24.1% YoY

Gross Profit

$1.1B39.9% margin

Operating Income

$228M8.4% margin

Net Income

$66M2.4% margin

EPS (Diluted)

$0.12

QoQ Revenue Growth

-16.8%

Cash Flow

Operating Cash Flow

$453M

Free Cash Flow

$395M

Stock-Based Comp.

$23M

Balance Sheet

Total Assets

$34.3B

Total Liabilities

$22.6B

Stockholders' Equity

$11.7B

Cash & Equivalents

$724M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.7B	$2.2B	+24.1%
Gross Profit	$1.1B	$907M	+19.6%
Operating Income	$228M	$106M	+115.6%
Net Income	$66M	$14M	+377.7%